Global Cardiac Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Cardiac Biomarkers Market is presumed to reach the market size of nearly USD 67.58 BN by 2030 from USD 18.2 BN in 2022 with a CAGR of 17.82% under the study period 2023 - 2030.

Cardiac biomarkers are protein molecules released into the bloodstream due to cardiac injury or stress. These biomarkers could be used to detect cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome, among other cardiovascular illnesses (ACS). Cardiac biomarker testing enables doctors to assess a patient's likelihood of developing such conditions. Troponin, creatine kinase-muscle/brain (CK-MB), B-type natriuretic peptide (BNP), high-sensitivity C-reactive protein (hs-CRP), troponin I and T, myoglobin, ischemia modified albumin (IMA), and other cardiac biomarkers are commonly employed as an integrated diagnostic method for cardiovascular diseases (CVDs).

Market Dynamics:

The market will likely be fueled by an increase in the senior population and patients suffering from heart attacks and chest discomfort due to changing lifestyles. The increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment, and research in which cardiac biomarkers are used are significant elements boosting the market growth. In addition, technological advancements in cardiac biomarkers and favourable government initiatives to raise awareness about cardiovascular diseases are the key factors driving the cardiac biomarkers market. Moreover, increased funding for cardiac biomarker research from both public and private institutions is likely to support market growth in the coming years. However, a lack of public awareness is projected to stifle industry expansion

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiac biomarkers. The growth and trends of cardiac biomarkers industry provide a holistic approach to this study.

Market Segmentation:

This section of the cardiac biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Myocardial Muscle Creatine Kinase (Ck-Mb)
Troponins (T And I)
Myoglobin
Brain Natriuretic Peptide (Bnps) Or Nt-Probnp
Ischemia Modified Albumin (Ima)
Others

By Application

Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

By Location of Testing

Point Of Care Testing
Laboratory Testing

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cardiac biomarkers market include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux, Randox laboratories, Beckman Coulter and Thermo Fisher Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11217049

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CARDIAC BIOMARKERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Type
- 3.7.2 By Application
- 3.7.3 By Location of Testing
- 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Myocardial muscle Creatine Kinase (CK-MB) Market by Regions
6.5 Troponins (T and I) Market by Regions
6.6 Myoglobin Market by Regions
6.7 Brain Natriuretic Peptide (BNPs) or NT-proBNP Market by Regions
6.8 Ischemia Modified Albumin (IMA) Market by Regions
6.9 Others Market by Regions

7 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Myocardial Infarction Market by Regions
7.5 Congestive Heart Failure Market by Regions
7.6 Acute Coronary Syndrome Market by Regions
7.7 Atherosclerosis Market by Regions
7.8 Others Market by Regions

8 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY LOCATION OF TESTING

8.1 Overview by Location of Testing
8.2 Historical and Forecast Data
8.3 Analysis by Location of Testing
8.4 Point of care Testing Market by Regions
8.5 Laboratory Testing Market by Regions

9 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America
- 9.3.1. Overview, Historic and Forecast Data
- 9.3.2. North America By Segment
- 9.3.3. North America By Country
- 9.3.4. United State
- 9.3.5. Canada
- 9.3.6. Mexico
9.4. Europe
- 9.4.1. Overview, Historic and Forecast Data
- 9.4.2. Europe by Segment
- 9.4.3. Europe by Country
- 9.4.4. United Kingdom
- 9.4.5. France
- 9.4.6. Germany
- 9.4.7. Italy
- 9.4.8. Russia
- 9.4.9. Rest Of Europe
9.5. Asia Pacific
- 9.5.1. Overview, Historic and Forecast Data
- 9.5.2. Asia Pacific by Segment
- 9.5.3. Asia Pacific by Country
- 9.5.4. China
- 9.5.5. India
- 9.5.6. Japan
- 9.5.7. South Korea
- 9.5.8. Australia
- 9.5.9. Rest Of Asia Pacific
9.6. Latin America
- 9.6.1. Overview, Historic and Forecast Data
- 9.6.2. Latin America by Segment
- 9.6.3. Latin America by Country
- 9.6.4. Brazil
- 9.6.5. Argentina
- 9.6.6. Peru
- 9.6.7. Chile
- 9.6.8. Rest of Latin America
9.7. Middle East & Africa
- 9.7.1. Overview, Historic and Forecast Data
- 9.7.2. Middle East & Africa by Segment
- 9.7.3. Middle East & Africa by Country
- 9.7.4. Saudi Arabia
- 9.7.5. UAE
- 9.7.6. Israel
- 9.7.7. South Africa
- 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE CARDIAC BIOMARKERS COMPANIES

10.1. Cardiac Biomarkers Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CARDIAC BIOMARKERS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Roche Diagnostics
- 11.3.1. Company Overview
- 11.3.2. Financials
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Abbott Laboratories
- 11.4.1. Company Overview
- 11.4.2. Financials
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Siemens Healthcare
- 11.5.1. Company Overview
- 11.5.2. Financials
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Alere Inc.
- 11.6.1. Company Overview
- 11.6.2. Financials
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Becton
- 11.7.1. Company Overview
- 11.7.2. Financials
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Dickinson and Company
- 11.8.1. Company Overview
- 11.8.2. Financials
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Bio-Rad Laboratories
- 11.9.1. Company Overview
- 11.9.2. Financials
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. BioMerieux
- 11.10.1. Company Overview
- 11.10.2. Financials
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Randox laboratories
- 11.11.1. Company Overview
- 11.11.2. Financials
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Beckman Coulter
- 11.12.1. Company Overview
- 11.12.2. Financials
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Thermo Fisher Scientific
- 11.13.1. Company Overview
- 11.13.2. Financials
- 11.13.3. Products
- 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies